Related Experiment Video
Updated: May 5, 2026

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
Influence of breastfeeding on blood-cell transcript-based biomarkers of health in children
1Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics), University of the Balearic Islands (UIB), Palma de Mallorca, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Palma de Mallorca, Spain.
Insights
Breastfeeding is linked to higher expression of key metabolic genes in children's blood cells, indicating a lower risk of obesity and related issues. These gene expression patterns can identify formula-fed infants at higher risk for metabolic problems.
Area of Science:
- Pediatric metabolic health
- Nutritional epigenetics
- Biomarker discovery
Background:
- Peripheral blood cell (PBC) gene expression can indicate metabolic status.
- Specific gene expressions (CPT1A, SLC27A2, INSR, LEPR, FASN, PPARα) in PBCs are linked to lower risk of insulin resistance and dyslipidemia in childhood obesity.
- Breastfeeding may offer protection against obesity and associated metabolic disturbances.
Purpose of the Study:
- To investigate the association between infant feeding type (breastfeeding vs. formula feeding) and the expression of specific transcriptional biomarkers of metabolic health in PBCs.
- To analyze the relationship between gene expression levels (SLC27A2, CPT1A, FASN, PPARα, INSR, LEPR) and metabolic health indicators in children.
- To explore the role of infant feeding in modulating metabolic health biomarkers within the IDEFICS cohort.
Main Methods:
- Study included 237 children aged 2-9 years from eight European countries.
- Analysis of gene expression levels in peripheral blood cells.
- Comparison of biomarker expression and metabolic health indicators between breastfed and formula-fed children.
Main Results:
- Breastfed children exhibited higher expression of SLC27A2, FASN, PPARα, and INSR compared to formula-fed children.
- Breastfed children had a lower risk of being overweight and presenting high plasma triglyceride levels.
- Formula-fed children with low expression of SLC27A2, FASN, PPARα, and INSR showed higher triglyceride levels, a difference not observed in breastfed children.
Conclusions:
- Breastfeeding's protective metabolic effects are evident through elevated expression of SLC27A2, FASN, PPARα, and INSR in blood cells.
- These gene expression biomarkers can differentiate formula-fed children at increased risk for metabolic alterations.
- Infant feeding type influences the relationship between PBC transcript levels and metabolic health markers like insulin resistance and dyslipidemia.
What Is Already Known About This Subject:
The expression of specific genes in peripheral blood cells (PBCs) may be used as biomarkers of the metabolic status. High levels of expression of CPT1A, SLC27A2, INSR, LEPR, FASN and PPARα in PBCs are indicative of a lower risk for the insulin resistant or dyslipidaemic state associated with obesity in children. Breastfeeding seems to confer protective effects against obesity and its related metabolic problems.
What This Study Adds:
Children who had been breastfed showed higher expression levels of SLC27A2, FASN, PPARα and INSR in PBCs compared with formula-fed subjects. The relationship of the PBC transcript levels of SLC27A2, INSR, FASN and PPARα with insulin resistance and dyslipidaemia may be dependent on the type of infant feeding (breast vs. formula). The transcript levels of the mentioned biomarkers could be useful to distinguish the formula-fed children who are at higher risk of metabolic alterations.
Background:
Blood-cell transcripts have showed to be good biomarkers of metabolic alterations and their use in early detection and prevention of future disorders is promising.
Objective:
This study aimed to examine the relation between previously proposed transcriptional biomarkers of metabolic health (SLC27A2, CPT1A, FASN, PPARα, INSR, LEPR) in peripheral blood cells and the type of infant feeding in a subset of children from the IDEFICS (Identification and Prevention of Dietary- and Lifestyle-Induced Health Effects in Children and Infants) cohort.
Subjects:
A total of 237 children aged 2-9 years from eight European countries were studied.
Results:
Breastfed children showed higher expression levels of SLC27A2, FASN, PPARα and INSR, and lower risk of being overweight and of having high plasma triglyceride levels vs. formula-fed children. Besides, overweight formula-fed children presented higher HOMA-index than overweight breastfed children (1.90 vs. 1.62); however, this negative effect was absent in formula-fed children with high expression of SLC27A2. Moreover, formula-fed children with low expression of SLC27A2, FASN, PPARα and INSR presented higher triglyceride levels than subjects with high expression of these genes (77.7 mg dL(-1) vs. 44.8 mg dL(-1) ). This difference was absent in breastfed children.
Conclusions:
Protective effects of breastfeeding are reflected in higher expression levels of SLC27A2, FASN, PPARα and INSR in blood cells. These biomarkers may also serve to discriminate the formula-fed children that are at higher risk of metabolic alterations.
Related Concept Videos
Development of Human Microbiota
Development of the Oral Microbiota
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Drug Distribution

